Ticker AQB – AquaBounty Tech – sales, description, marketcap – Tickerday.com

AQB

AquaBounty Tech

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 193.54M; Volume: 205.55K; AvgVol 3m: 823.87K; Beta: –;

Cost estimate:

P/E: –; EPS: -0.52; EPS growth quarter/prev quarter: 41.90%;

EPS growth this year: 17.30%; EPS growth past 5 years: 15.40%;

EPS ttm: -0.52;

P/S: 3296.83; P/B: 4.32; P/Cashflow: ; P/FCF: ;

Sales: 60.00K; Sales growth quarter/prev quarter: -93.10%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -36.50%; ROE – return on equity: -44.50%; LT Debt/Equity: 0.14; Total Debt/Equity: 0.14;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.30%; Insider Transactions:;

Institutional Ownership: 43.20%; Institutional Transactions: 1.78%;

Data update: 07/10/2020.